URCC21038 DiRECT Amendment 1 Webinar

We are pleased to offer a Webinar opportunity for URCC21038 DiRECT. This will be held on Friday April 12, 2024, from 1:00pm – 2:00pm (EST) eastern time. 

Please remember to use your first and last name when signing into Zoom to attend the Webinar.

**Special Note**

This is a Webinar to introduce major changes in Amendment 1 that will be activated soon!

The primary purpose of the study is to compare immune related adverse events (irAE) between AA and EA patients with first year of starting immune checkpoint inhibitors (ICI’s).

See news post for zoom details.